A scalable serology solution for profiling humoral immune responses to SARS‐CoV‐2 infection and vaccination-Reference-Cited by-同舟云学术

A scalable serology solution for profiling humoral immune responses to SARS‐CoV‐2 infection and vaccination

Published:2022-01 Issue:3 Volume:11 Page:
ISSN:2050-0068
Container-title:Clinical & Translational Immunology
language:en
Short-container-title:Clin & Trans Imm

Author:

Colwill Karen¹^ORCID,Galipeau Yannick²,Stuible Matthew³,Gervais Christian³,Arnold Corey²,Rathod Bhavisha¹,Abe Kento T¹⁴,Wang Jenny H¹,Pasculescu Adrian¹,Maltseva Mariam²,Rocheleau Lynda²,Pelchat Martin²⁵,Fazel‐Zarandi Mahya¹,Iskilova Mariam¹,Barrios‐Rodiles Miriam¹,Bennett Linda¹,Yau Kevin⁶,Cholette François⁷⁸,Mesa Christine⁷,Li Angel X¹⁹,Paterson Aimee¹⁹,Hladunewich Michelle A⁶,Goodwin Pamela J¹¹⁰,Wrana Jeffrey L¹⁴,Drews Steven J¹¹¹²,Mubareka Samira¹³¹⁴¹⁵¹⁶,McGeer Allison J¹⁹¹⁷,Kim John⁷,Langlois Marc‐André²⁵^ORCID,Gingras Anne‐Claude¹⁴^ORCID,Durocher Yves³^ORCID

Affiliation:

1. Lunenfeld‐Tanenbaum Research Institute at Mount Sinai Hospital Sinai Health Toronto ON Canada

2. Department of Biochemistry, Microbiology, and Immunology University of Ottawa Ottawa ON Canada

3. Mammalian Cell Expression, Human Health Therapeutics Research Centre National Research Council Canada Montréal QC Canada

4. Department of Molecular Genetics University of Toronto Toronto ON Canada

5. The Centre for Infection, Immunity, and Inflammation University of Ottawa Ottawa ON Canada

6. Division of Nephrology Department of Medicine Sunnybrook Health Sciences Centre Toronto ON Canada

7. National Microbiology Laboratory Public Health Agency of Canada Winnipeg MB Canada

8. Department of Medical Microbiology and Infectious Diseases University of Manitoba Winnipeg MB Canada

9. Department of Microbiology, at Mount Sinai Hospital Sinai Health Toronto ON Canada

10. Department of Medicine University of Toronto Toronto ON Canada

11. Microbiology, Donation Policy and Studies Canadian Blood Services Edmonton AB Canada

12. Division of Diagnostic and Applied Microbiology Department of Laboratory Medicine and Pathology University of Alberta Edmonton AB Canada

13. Division of Microbiology Department of Laboratory Medicine and Molecular Diagnostics Sunnybrook Health Sciences Centre Toronto ON Canada

14. Biological Sciences Sunnybrook Research Institute Toronto ON Canada

15. Division of Infectious Diseases Sunnybrook Health Sciences Centre Toronto ON Canada

16. Department of Laboratory Medicine and Pathology University of Toronto Toronto ON Canada

17. Institute of Health Policy, Management and Evaluation University of Toronto Toronto ON Canada

Funder

Genome Canada

Ontario Genomics

Canada Foundation for Innovation

Royal Bank of Canada

Canadian Institutes of Health Research

Public Health Agency of Canada

Ontario Ministry of Research, Innovation and Science

National Research Council Canada

Krembil Foundation

Publisher

Wiley

Subject

General Nursing,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cti2.1380

Reference49 articles.

1. Johns Hopkins University COVID‐19 dashboard. [cited February 25 2021]. Available from:https://coronavirus.jhu.edu/map.html

2. Few Canadians had antibodies against SARS‐CoV‐2 in early 2021 – Statistics Canada. [updated July 6 2021; cited February 25 2022]. Available from:https://www150.statcan.gc.ca/n1/daily‐quotidien/210706/dq210706a‐eng.htm

3. Serotracker. [updated February 22 2022; cited February 25 2022]. Available from:https://serotracker.com/en/Explore

4. Effectiveness of BNT162b2 and mRNA-1273 covid-19 vaccines against symptomatic SARS-CoV-2 infection and severe covid-19 outcomes in Ontario, Canada: test negative design study

5. Health Infobase Canada – COVID‐19 vaccination coverage. [updated February 18 2022; cited February 25 2022]. Available from:https://health‐infobase.canada.ca/covid‐19/vaccination‐coverage/

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19 vaccine immunogenicity and safety surrounding fourth and subsequent vaccine doses in patients with hematologic malignancies;Vaccine;2024-10

2. High SARS-CoV-2 seroincidence but low excess COVID mortality in Sierra Leone in 2020–2022;PLOS Global Public Health;2024-09-10

3. Seroprevalence of SARS-CoV-2 antibodies among children receiving primary care in Toronto, Ontario;Canadian Journal of Public Health;2024-08-21

4. Comparison of the analytical sensitivity of COVID-19 rapid antigen tests in Australia and Canada;Talanta;2024-08

5. Hybrid immunity after BNT162b2 Covid-19 vaccine administration in children aged 5 to 11 years;Vaccine;2024-08